Comparison of the efficacy and complications of endoscopic incisional therapy and balloon dilatation for benign esophageal strictures

Eun Jeong Choi, S. Jee, Sang Heon Lee, Ji Hyun Kim, J. Yoon, J. Heo, S. Yu, Hee Won Baek, Hong Sub Lee
{"title":"Comparison of the efficacy and complications of endoscopic incisional therapy and balloon dilatation for benign esophageal strictures","authors":"Eun Jeong Choi, S. Jee, Sang Heon Lee, Ji Hyun Kim, J. Yoon, J. Heo, S. Yu, Hee Won Baek, Hong Sub Lee","doi":"10.7180/kmj.22.128","DOIUrl":null,"url":null,"abstract":"Background: Benign esophageal strictures are treated endoscopically, often with balloon dilatation (BD) or bougie dilators. However, recurrent esophageal strictures have been reported after BD, and severe complications sometimes occur. The aim of this study was to compare the efficacy and complications of endoscopic incisional therapy (EIT) and BD for benign esophageal strictures. Methods: We retrospectively reviewed patients who underwent BD or EIT as primary treatment for benign esophageal strictures between July 2014 and June 2021. Technical success was defined as restoration of the lumen diameter with <30% residual stenosis. Clinical success was defined as no recurrence of dysphagia within 1 month after BD or EIT and an increase of 1 grade or more on the Functional Oral Intake Scale. Results: Thirty patients with benign esophageal stricture were enrolled. There were 16 patients in the BD group and 14 patients in the EIT group. No significant differences in technical and clinical success rates were found between the two groups. Furthermore, no significant differences in the re-stricture rate were observed between the groups. There was one complication in the EIT group and three complications in the BD group. Three patients who underwent BD had re-stricture and underwent EIT thereafter, and we regrouped patients who underwent EIT at least once. The clinical success rate was significantly higher in patients regrouped to the EIT group than in patients who underwent BD only. Conclusions: EIT is not inferior to BD as the primary treatment for benign esophageal strictures, especially for recurrent cases.","PeriodicalId":53015,"journal":{"name":"Kosin Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kosin Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7180/kmj.22.128","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Benign esophageal strictures are treated endoscopically, often with balloon dilatation (BD) or bougie dilators. However, recurrent esophageal strictures have been reported after BD, and severe complications sometimes occur. The aim of this study was to compare the efficacy and complications of endoscopic incisional therapy (EIT) and BD for benign esophageal strictures. Methods: We retrospectively reviewed patients who underwent BD or EIT as primary treatment for benign esophageal strictures between July 2014 and June 2021. Technical success was defined as restoration of the lumen diameter with <30% residual stenosis. Clinical success was defined as no recurrence of dysphagia within 1 month after BD or EIT and an increase of 1 grade or more on the Functional Oral Intake Scale. Results: Thirty patients with benign esophageal stricture were enrolled. There were 16 patients in the BD group and 14 patients in the EIT group. No significant differences in technical and clinical success rates were found between the two groups. Furthermore, no significant differences in the re-stricture rate were observed between the groups. There was one complication in the EIT group and three complications in the BD group. Three patients who underwent BD had re-stricture and underwent EIT thereafter, and we regrouped patients who underwent EIT at least once. The clinical success rate was significantly higher in patients regrouped to the EIT group than in patients who underwent BD only. Conclusions: EIT is not inferior to BD as the primary treatment for benign esophageal strictures, especially for recurrent cases.
内镜下切口治疗与球囊扩张治疗食管良性狭窄的疗效及并发症比较
背景:良性食管狭窄是通过内镜治疗的,通常使用球囊扩张(BD)或探条扩张器。然而,据报道,BD术后复发性食管狭窄,有时会出现严重并发症。本研究的目的是比较内镜下切口治疗(EIT)和BD治疗良性食管狭窄的疗效和并发症。方法:我们回顾性回顾了2014年7月至2021年6月期间接受BD或EIT作为良性食管狭窄主要治疗的患者。技术上的成功被定义为管腔直径的恢复,残余狭窄<30%。临床成功被定义为BD或EIT后1个月内没有吞咽困难复发,并且在功能性口腔摄入量表上增加了1级或以上。结果:30例良性食管狭窄患者入选。BD组有16名患者,EIT组有14名患者。两组在技术和临床成功率方面没有发现显著差异。此外,两组之间的再狭窄率没有显著差异。EIT组有1例并发症,BD组有3例并发症。三名接受BD的患者再次狭窄,随后接受了EIT,我们对至少接受过一次EIT的患者进行了重新分组。重新分组到EIT组的患者的临床成功率明显高于仅接受BD的患者。结论:EIT作为治疗良性食管狭窄,尤其是复发性食管狭窄的主要方法,并不劣于BD。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
40
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信